CoCensys Inc.: The Irvine developer of neuropharmaceutical...
- Share via
CoCensys Inc.: The Irvine developer of neuropharmaceutical products reported a first-quarter loss of $4.6 million, or 50 cents a share, which included a onetime charge of $2 million advanced to an affiliate. That compared to a loss of $2.2 million, or 27 cents a share, for the first quarter of 1993. The company reported no revenue.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
